Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Gut Microbiota Market Size And Revenue Outlook Through 2030
The gut microbiota market size has seen rapid expansion in recent years. It is projected to increase from $0.65 billion in 2025 to $0.77 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 18.0%. The growth observed in the past can be linked to an enhanced understanding of gut health and immunity, the growing consumption of dietary supplements, the expansion of functional food markets, increased academic research focusing on microbiota, and a rising consumer awareness regarding digestive health.
The gut microbiota market size is poised for substantial expansion in the coming years, with expectations to reach $1.47 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 17.7%. This growth over the forecast period is propelled by the escalating development of therapeutics aimed at the microbiome, increasing financial commitments to gut health research, the widening scope of personalized nutrition platforms, the growing integration of microbiome diagnostic tools, and a heightened emphasis on healthcare solutions focused on prevention. Notable trends anticipated during this period include a greater embrace of probiotic and prebiotic products, an intensifying focus on tailored nutrition approaches, expanding investigation into microbiome-based treatments, an increase in the consumption of functional and fermented foods, and enhanced deployment of gut health diagnostic instruments.
Get A Free Sample Report With In-Depth Market Insights:
Gut Microbiota Market Growth Catalysts And Demand Drivers
The expanding need for personalized medicine is anticipated to fuel the growth of the gut microbiota market moving forward. This approach involves customizing treatments for individual patients, considering their genetic, environmental, and lifestyle elements to enhance results and improve care. The demand for personalized medicine is increasing because breakthroughs in genomics and biotechnology enable more precise identification of genetic profiles, allowing for customized therapies that boost efficacy and lessen adverse effects. For gut microbiota, personalized medicine is beneficial as it tailors treatments based on an individual’s distinct microbiome composition, thereby optimizing gut health and improving outcomes for digestive and metabolic conditions. As an illustration, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, noted that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a considerable increase from the 12 approved in 2022. Consequently, the rising demand for personalized medicine is propelling the expansion of the gut microbiota market.
Gut Microbiota Market Segment Landscape: Which Areas Lead Development?
The gut microbiota market covered in this report is segmented –
1) By Product: Prebiotics, Probiotics, Drugs, Supplements, Other Products
2) By Application: Digestive Health, Immune Health, Weight Management, Mental Health, Cardiovascular Health
3) By Distribution Channel: Pharmacies And Drugstores, Online Retail, Health Food Stores, Supermarkets And Hypermarkets, Specialty Stores
4) By End-Users: Adults, Children, Elderly
Subsegments:
1) By Prebiotics: Fructooligosaccharides (Fos), Galactooligosaccharides (Gos), Inulin, Resistant Starch, Beta-Glucans, Arabinogalactans, Pectins
2) By Probiotics: Lactobacillus, Bifidobacterium, Saccharomyces, Streptococcus, Bacillus, Escherichia
3) By Drugs: Antibiotics, Bacteriophage Therapy, Gut Microbiota Modulators, Immunomodulators, Antidiarrheal Agents, Laxatives
4) By Supplements: Synbiotics, Postbiotics, Enzyme Supplements, Vitamin D Supplements, Omega-3 Fatty Acids, Herbal Extracts
5) By Other Products: Functional Foods, Fermented Foods, Beverages, Gut Health Diagnostic Kits, Dietary Fiber Products
Gut Microbiota Market Industry Trends: What’s Reshaping Demand?
Leading companies in the gut microbiota market are increasingly focusing on developing innovative solutions, such as orally administered fecal microbiota, to address a variety of gastrointestinal diseases and disorders. Orally administered fecal microbiota involves a treatment where a capsule or pill containing beneficial bacteria from a healthy donor’s stool is consumed to restore balance to the gut microbiome. For instance, in April 2023, Seres Therapeutics Inc., a US-based microbiome therapeutics platform company, obtained FDA approval for Vowst, which is the first oral fecal microbiota product specifically designed to prevent recurrent Clostridioides difficile (C. difficile) infection (CDI) in individuals aged 18 and older. Vowst is intended for use subsequent to antibacterial treatment for recurrent CDI. This approval signifies a major advancement in CDI treatment, presenting a more accessible and patient-friendly alternative to traditional fecal microbiota transplants, which are typically delivered via colonoscopy or enema. Its oral formulation is expected to improve treatment adherence and expand the adoption of microbiome-based therapies in healthcare settings.
Gut Microbiota Market Industry Leaders And Competitive Landscape
Major companies operating in the gut microbiota market are Danone S.A., DuPont de Nemours Inc., International Flavors & Fragrances Inc., Seres Therapeutics, Yakult Honsha Co. Ltd., Chr. Hansen Holding A/S, Lallemand Inc., Lifeway Foods Inc., BioGaia AB, Probi AB, Seed Health, Enterome, Vedanta Biosciences Inc., Evolve BioSystems Inc., Winclove Probiotics B.V., Kallyope Inc., Sun Genomics Inc., Synlogic Inc., OpenBiome, Codex Labs Corp.
View The Full Gut Microbiota Market Report:
Gut Microbiota Market Top Region: Where Does Most Revenue Come From?
North America was the largest region in the gut microbiota market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gut microbiota market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
